At a glance
ClinicalIndex Comparison RecordN/ACompleted· 10 enrolled
Drug / intervention
warfarin plus rifampin +1 moredrug
Likely dose
warfarin plus rifampin 7.5mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
The Effects of Rifampin on the Pharmacokinetics of Warfarin in Healthy Volunteers.
In Brief
A clinical study evaluating warfarin plus rifampin and warfarin for Healthy. Completed, enrolled 10 participants across 1 site.
Detailed Summary
The purpose of this study is to determine the importance of uptake drug transporters in the drug disposition of warfarin. We predict that the elimination of warfarin will be decreased when co-dosed with an inhibitor of uptake drug transporters.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHealthy
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
200920102011201220132014201520162017201820192020202120222023202420252026
First PostedOct 2008
Enrollment StartNov 2008
Primary CompletionMar 2009
TodayJul 2026
First PostedOct 22, 2008
Enrollment StartNov 1, 2008
Primary CompletionMar 1, 2009
TodayJul 2, 2026
Enrollment to primary: 4 monthsPosted 17.7 years ago
Interventions
warfarin plus rifampindrug
warfarin 7.5mg po x 1; rifampin 600mg IV x 1
warfarindrug
warfarin 7.5mg po x 1